Lung Microbiome Analysis in Steroid-Naїve Asthma Patients by Using Whole Sputum

Background Although recent metagenomic approaches have characterized the distinguished microbial compositions in airways of asthmatics, these results did not reach a consensus due to the small sample size, non-standardization of specimens and medication status. We conducted a metagenomics approach by using terminal restriction fragment length polymorphism (T-RFLP) analysis of the induced whole sputum representing both the cellular and fluid phases in a relative large number of steroid naïve asthmatics. Methods Induced whole sputum samples obtained from 36 healthy subjects and 89 steroid-naїve asthma patients were analyzed through T-RFLP analysis. Results In contrast to previous reports about microbiota in the asthmatic airways, the diversity of microbial composition was not significantly different between the controls and asthma patients (p=0.937). In an analysis of similarities, the global R-value showed a statistically significant difference but a very low separation (0.148, p=0.002). The dissimilarity in the bacterial communities between groups was 28.74%, and operational taxonomic units (OTUs) contributing to this difference were as follows: OTU 789 (Lachnospiraceae), 517 (Comamonadaceae, Acetobacteraceae , and Chloroplast), 633 (Prevotella), 645 (Actinobacteria and Propionibacterium acnes), 607 (Lactobacillus buchneri, Lactobacillus otakiensis, Lactobacillus sunkii, and Rhodobacteraceae), and 661 (Acinetobacter, Pseudomonas, and Leptotrichiaceae), and they were significantly more prevalent in the sputum of asthma patients than in the sputum of the controls. Conclusion Before starting anti-asthmatic treatment, the microbiota in the whole sputum of patients with asthma showed a marginal difference from the microbiota in the whole sputum of the controls.

[1]  T. Junt,et al.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.

[2]  P. Howarth,et al.  Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma , 2014, PloS one.

[3]  J. Tiedje,et al.  Alterations of the Murine Gut Microbiome with Age and Allergic Airway Disease , 2015, Journal of immunology research.

[4]  M. Noval Rivas,et al.  The microbiome in asthma , 2016, Current opinion in pediatrics.

[5]  T. Marsh.  Terminal restriction fragment length polymorphism (T-RFLP): an emerging method for characterizing diversity among homologous populations of amplification products. , 1999, Current opinion in microbiology.

[6]  Gheyath K Nasrallah,et al.  Human Microbiome and its Association With Health and Diseases , 2016, Journal of cellular physiology.

[7]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[8]  M. Hartmann,et al.  Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthma , 2012, EMBO reports.

[9]  S. Chotirmall,et al.  Aging and the microbiome: implications for asthma in the elderly? , 2015, Expert review of respiratory medicine.

[10]  Tanja Woyke,et al.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. , 2011, The Journal of allergy and clinical immunology.

[11]  J. Fortenberry.  The uses of race and ethnicity in human microbiome research. , 2013, Trends in microbiology.

[12]  Dean Billheimer,et al.  Asthma-associated differences in microbial composition of induced sputum. , 2013, The Journal of allergy and clinical immunology.

[13]  R. Sartor,et al.  Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome , 2010, Gut pathogens.

[14]  R. Sartor,et al.  Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[15]  Yvonne J. Huang.  The respiratory microbiome and innate immunity in asthma , 2015, Current opinion in pulmonary medicine.

[16]  S. Johnston,et al.  The microbiology of asthma , 2012, Nature Reviews Microbiology.

[17]  E. Castro-Nallar,et al.  Dual Transcriptomic Profiling of Host and Microbiota during Health and Disease in Pediatric Asthma , 2015, PloS one.

[18]  F. Blasi,et al.  Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection , 2008, Respiratory research.

[19]  K. Min,et al.  Original article: Evaluation of cytokine mRNA in induced sputum from patients with allergic rhinitis: relationship to airway hyperresponsiveness , 2007, Allergy.

[20]  P. Holt.  The mechanism or mechanisms driving atopic asthma initiation: The infant respiratory microbiome moves to center stage. , 2015, The Journal of allergy and clinical immunology.

[21]  Anders F. Andersson,et al.  Low Gut Microbiota Diversity in Early Infancy Precedes Asthma at School Age , 2015, Pediatrics.

[22]  J. Curtis,et al.  Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome , 2015, mBio.

[23]  Yoshihide Fujiyama,et al.  Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis , 2007, Inflammatory bowel diseases.

[24]  Sang-Gue Park,et al.  Microbial Communities in the Upper Respiratory Tract of Patients with Asthma and Chronic Obstructive Pulmonary Disease , 2014, PloS one.

[25]  Jodie L Simpson,et al.  Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma , 2015, European Respiratory Journal.

[26]  S. Lynch,et al.  Influence and effect of the human microbiome in allergy and asthma , 2015, Current opinion in rheumatology.

[27]  Christopher J. Williams,et al.  Advances in the use of terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes to characterize microbial communities , 2008, Applied Microbiology and Biotechnology.

[28]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[29]  Y. Benno,et al.  Faecal microbiota profile of Crohn’s disease determined by terminal restriction fragment length polymorphism analysis , 2009, Alimentary pharmacology & therapeutics.

[30]  Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling , 2003, Journal of Clinical Microbiology.

[31]  Hans Bisgaard,et al.  Childhood asthma after bacterial colonization of the airway in neonates. , 2007, The New England journal of medicine.

[32]  W. Webley,et al.  Infectious asthma triggers: time to revise the hygiene hypothesis? , 2015, Trends in microbiology.

[33]  O. Inatomi,et al.  Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis , 2011, Journal of Gastroenterology.

[34]  M. Moffatt,et al.  Upper Airways Microbiota in Antibiotic-Naïve Wheezing and Healthy Infants from the Tropics of Rural Ecuador , 2012, PloS one.

[35]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[36]  S. Wenzel.  Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.

[37]  Mitsuo Sakamoto,et al.  Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. , 2005, Journal of microbiological methods.

[38]  G. Rogers,et al.  Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.

[39]  Donald Y M Leung,et al.  The effects of airway microbiome on corticosteroid responsiveness in asthma. , 2013, American journal of respiratory and critical care medicine.